Albireo Pharma - Crunchbase Company Profile & Funding

Q: Who invested in Albireo Pharma?

Albireo Pharma has 2 investors including TVM Capital And TPG Growth.

Q: When was the last funding round for Albireo Pharma?

Albireo Pharma closed its last funding round on obfuscated from a Post-IPO Equity round.

Q: How much funding has Albireo Pharma raised to date?

Albireo Pharma has raised obfuscated.

Overview

Albireo Pharma

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Albireo Pharma

CB Rank

181458

Albireo Pharma a biotechnology company develops therapeutic drugs for gastrointestinal diseases.

Acquired by

Ipsen

Founded

obfuscation

Public

Post-IPO Equity

Gothenburg, Vastra Gotaland, Sweden

101-250

www.albireopharma.com

Biotechnology

Health Care

Therapeutics

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Simon Harford: Chief Financial Officer
David Chiswell: Executive Chairman

Details

Legal Name

Albireo Pharma, Inc.

Operating Status

Closed

Stock Symbol

NASDAQ:ALBO

Company Type

For Profit

About the Company

Albireo Pharma is a rare disease company dedicated to the discovery and development of novel bile acid modulators for the treatment of pediatric and adult liver diseases.

Phone Number

46 3 17 41 14 80

Predictions & Insights

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Albireo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Albireo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Albireo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Albireo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Albireo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Albireo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Albireo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Albireo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Albireo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Albireo Pharma	—	obfuscated obfuscation	—	Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
TVM Capital	—	Series A - Albireo Pharma	—
TVM Capital	—	Series A - Albireo Pharma	—
TVM Capital	—	Series A - Albireo Pharma	—
TVM Capital	—	Series A - Albireo Pharma	—
TVM Capital	—	Series A - Albireo Pharma	—